Sanofi, the international pharmaceutical giant, acquired a stake in the drug delivery start-up Livmed’s on 22 November. Via its para-pharmacy subsidiary Sanofi Santé Grand Public (para-pharmacy, which accounted for 10.2% of the group’s turnover in Q3 2022), the laboratory contributed €1 million to this €5 million fundraising.
Do you have information to share with us?